Article
Multi-omics analysis of renal clear cell carcinoma progression
2022-11-22
Abstract excerpt
Renal clear cell carcinoma (RCC), the most common type of kidney cancer, lacks a well-defined collection of biomarkers for tracking disease progression. Although complementary diagnostic and prognostic RCC biomarkers may be beneficial for guiding therapeutic selection and informing clinical outcomes, patients currently have a poor prognosis due to limited early detection. Without a priori biomarker knowledge or hi...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- 483fed2a-0941-5056-9a8c-92d58bc0127c
- DOI
- 10.1101/2022.11.21.22282533
